NIH-funded research R01 grant

Developing a new type of artificial blood to carry oxygen.

Official title: Preclinical Evaluation of a Peptide-amphiphile Derived Toroidal Oxygen Carrier

Funded at Pennsylvania State University, the · NIH-11047274 · Data updated 2026-11-12

This study is working on a new type of artificial blood that can safely deliver oxygen in situations where regular blood isn't available, making it helpful for patients who need blood transfusions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State University, the
NIH-funded
Lab location1 site (University Park, United States)
Project startFebruary 1, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$715,110
NIH project number1R01HL173540-01A1
Project IDNIH-11047274 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals requiring blood transfusions in emergency or surgical settings where traditional blood products are unavailable.

Less likely to help

Patients with conditions that do not require blood transfusions or those who have specific allergies to components of the artificial blood may not benefit from this research.

What this research studies

This research focuses on creating a novel artificial oxygen carrier that can serve as a substitute for traditional banked blood. The approach involves designing a blood substitute prototype that mimics the structure of red blood cells and incorporates hemoglobin for effective oxygen delivery. Utilizing advanced machine learning and synthetic biology techniques, the project aims to optimize the properties of this artificial blood to ensure it functions safely and effectively in the body. The goal is to produce a product that can be stored and used in medical situations where conventional blood supplies are not available.

Why it matters

Potential benefit: If successful, this research could provide a safe and effective alternative to banked blood, potentially saving lives in emergency situations.

How similar studies have gone: Previous research on hemoglobin-based oxygen carriers has faced challenges, but this innovative approach using nanoparticle technology and machine learning represents a novel direction in the field.

Where this research is happening

  • Pennsylvania State University, the
    University Park, United States
    Active

Researchers

  • Principal investigator: Pan, Dipanjan — Pennsylvania State University, the
  • Study coordinator: Pan, Dipanjan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.